Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MMC

Financiado

Membrane Micro-Compartments

More than two-thirds of all described drug targets are membrane proteins, but only for a small fraction of these hydrophobic proteins the structure is currently known. Membrane proteins are inherently challenging to produce and an... ver más

31/07/2025

MPG

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-01-24

ERC-2023-POC: ERC PROOF OF CONCEPT GRANTS Objective:Objectives:The ERC Proof of Concept Grants aim at facilitating exploration of the commerci...

I+D

Cerrada hace 1 año

0% 100% 100%

1 Participantes

MPG

150.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BFU2009-08401 EXPRESION, PLEGAMIENTO Y DINAMICA DE PROTEINAS DE MEMBRANA 206K€ Cerrado

RYC-2013-13114 structure, dynamics and function of membrane proteins 309K€ Cerrado

BFU2008-04637 CONTRUCCION DE UNA PROTEINA POLITOPICA DE MEMBRANA TERMOESTA... 109K€ Cerrado

BES-2010-038274 ESTRUCTURA Y DINAMICA EN LA FUNCION DE PROTEINAS DE MEMBRANA... 43K€ Cerrado

BFU2012-36241 PROTEINAS DE MEMBRANA: MUCHAS PREGUNTAS SIN RESPUESTA. 197K€ Cerrado

RAMP RAtionalising Membrane Protein crystallisation 3M€ Cerrado

Duración del proyecto: 18 meses Fecha Inicio: 2024-01-24
Fecha Fin: 2025-07-31

Líder del proyecto

MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 150K€

Descripción del proyecto More than two-thirds of all described drug targets are membrane proteins, but only for a small fraction of these hydrophobic proteins the structure is currently known. Membrane proteins are inherently challenging to produce and analyze. Consequently, in pre-clinical investigations their mechanism and drug interactions are often only derived from purified truncated parts of these proteins, taken out of their native biological context. Lacking the effects of surrounding membrane components, conclusions on drug mechanisms are indecisive. Recent advances in in situ structure determination techniques, i.e. analysis directly within the cellular environment, now have the power to overcome the limitations of classical reconstituted approaches. Complementary, we have developed a system that may facilitate structural analysis of membrane protein drug targets and has large potential for the production of native membrane proteins - an essential prerequisite for the study of membrane protein function and drug interactions. Within the scope of our proposal, we will further develop our system and transfer it into pharmaceutically relevant cell systems. Furthermore, we aim to achieve proof-of-concept and assess our system with clinically relevant membrane proteins for their suitability to solve 3D structures in complex with clinical drugs, as well as its suitability for the membrane protein production. We are convinced that our approach will have a transformative impact on how drug - membrane protein interactions can be studied, and could be exploited for drug development in the pharmaceutical industry. In the course of the project, we will establish a plan for transforming our system into a business model and commercializing our technology.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores